Aethlon Medical announces 1-for-10 reverse stock split

Aethlon Medical announced that its Board of Directors has approved a 1-for-10 reverse stock split of the company’s common stock, effective at 5:00 p.m. ET on October 4, 2023. The company’s shares of common stock will begin trading on a reverse split-adjusted basis commencing upon market opening on October 5, 2023. At the company’s Annual Meeting of Stockholders, held on September 15, 2023, a reverse stock split of the company’s common stock at a ratio in the range of 1-for-8 to 1-for-12 was approved, with such ratio to be determined at the discretion of the company’s Board of Directors and with such reverse stock split to be effected at such time and date as determined by the Board in its sole discretion.